CAM
HQL

Costello Asset Management’s abrdn Life Sciences Investors HQL Stock Holding History

Costello Asset Management’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.6K Buy
1,080
+60
+6% +$1K 0.01% 407
2025
Q4 		$17.1K Sell
1,020
-174
-15% -$2.92K 0.01% 399
2025
Q3 		$18.5K Sell
1,194
-509
-30% -$6.97K 0.01% 383
2025
Q2 		$21.8K Buy
1,703
+47
+3% +$579 0.01% 352
2025
Q1 		$21K Buy
+1,656
New +$22.4K 0.01% 337

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Costello Asset Management's HQL Position: Q1 2026 in Review

Costello Asset Management increased its abrdn Life Sciences Investors (HQL) stake by 5.9% in Q1 2026, buying an estimated $1K and bringing the position to 1,080 shares worth $17.6K. The position accounts for 0.01% of the portfolio, ranked #407.

Costello Asset Management first reported a position in HQL in Q1 2025 and has held it in 5 quarters since. The position peaked at $21.8K in Q2 2025. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.

  • Costello Asset Management held 1,080 shares of abrdn Life Sciences Investors worth $17.6K as of Q1 2026.
  • Costello Asset Management bought 60 abrdn Life Sciences Investors shares in Q1 2026, an estimated $1K.
  • abrdn Life Sciences Investors made up 0.01% of Costello Asset Management's portfolio in Q1 2026, its #407 holding.
  • Costello Asset Management first reported a position in abrdn Life Sciences Investors in Q1 2025 and has held it in 5 quarters since.
  • Costello Asset Management's abrdn Life Sciences Investors position peaked at $21.8K in Q2 2025.
  • 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.

Based on Costello Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.